New cancer drug begins first human testing
Disease control
Recruiting now
This is the first study in humans to test a new drug called ARC101 for people with advanced solid tumors. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also look for early signs that the drug might help shrink tumors.
Phase: PHASE1 • Sponsor: Third Arc Bio • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC